Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Adjuvants and immunoeffectors from AGP series under evaluation at Ribi

Feb. 9, 1999

NIH seeks licensees and/or CRADA partners for development of HCV vaccine

Feb. 9, 1999

Novartis describes new PNP inhibitor series in recent patent literature

Feb. 8, 1999

Novel ferrioxamine immunosuppressant discovered at Japanese research institutes

Feb. 5, 1999

Abgenix reports positive preliminary results from phase II trial of GVHD treatment

Feb. 5, 1999

EMEA marketing approval for Triacelluvax

Feb. 4, 1999

New immunomodulator LK-423 possesses unique pharmacological properties

Feb. 3, 1999

Clinical trials for Japanese immunosuppressant begin in Europe

Feb. 3, 1999

Priority review status assigned to Rapamune immunosuppressive therapy

Feb. 3, 1999

New herpes vaccine from Cel-Sci proves effective in protecting mice

Feb. 1, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...